A phase II study of combination therapy with oral S-1 and cisplatin in elderly patients with advanced gastric cancer

被引：0
|
作者：
Yusuke Sasaki
Satoru Iwasa
Shunsuke Okazaki
Masahiro Goto
Yasushi Kojima
Atsushi Naganuma
Kengo Nagashima
Yushi Nagai
Hidekazu Hirano
Yoshitaka Honma
Atsuo Takashima
Ken Kato
Tetsuya Hamaguchi
机构：
[1] National Cancer Center Hospital,Gastrointestinal Medical Oncology Division
[2] National Hospital Organization Kyoto Medical Center,Medical Oncology Division
[3] Osaka Medical College Hospital,Cancer Chemotherapy Center
[4] National Center for Global Health and Medicine,Department of Gastroenterology
[5] National Hospital Organization Takasaki General Medical Center,Department of Gastroenterology
[6] Chiba University Graduate School of Medicine,Department of Global Clinical Research
[7] National Cancer Center Hospital,Clinical Trial Support Office
来源：
Gastric Cancer | 2018年 / 21卷
关键词：
Cisplatin; Elderly patient; Gastric cancer; S-1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：439 / 445
页数：6
相关论文
共 50 条
  • [31] Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer
    Bando, Hideaki
    Yamada, Yasuhide
    Tanabe, Satoshi
    Nishikawa, Kazuhiro
    Gotoh, Masahiro
    Sugimoto, Naotoshi
    Nishina, Tomohiro
    Amagai, Kenji
    Chin, Keisho
    Niwa, Yasumasa
    Tsuji, Akihito
    Imamura, Hiroshi
    Tsuda, Masahiro
    Yasui, Hirofumi
    Fujii, Hirofumi
    Yamaguchi, Kensei
    Yasui, Hisateru
    Hironaka, Shuichi
    Shimada, Ken
    Miwa, Hiroto
    Hamada, Chikuma
    Hyodo, Ichinosuke
    GASTRIC CANCER, 2016, 19 (03) : 919 - 926
  • [32] Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer
    Hideaki Bando
    Yasuhide Yamada
    Satoshi Tanabe
    Kazuhiro Nishikawa
    Masahiro Gotoh
    Naotoshi Sugimoto
    Tomohiro Nishina
    Kenji Amagai
    Keisho Chin
    Yasumasa Niwa
    Akihito Tsuji
    Hiroshi Imamura
    Masahiro Tsuda
    Hirofumi Yasui
    Hirofumi Fujii
    Kensei Yamaguchi
    Hisateru Yasui
    Shuichi Hironaka
    Ken Shimada
    Hiroto Miwa
    Chikuma Hamada
    Ichinosuke Hyodo
    Gastric Cancer, 2016, 19 : 919 - 926
  • [33] A late phase II study of S-1 in patients with advanced gastric cancer
    Ohtsu, A
    Sakata, Y
    Horikoshi, N
    Mitachi, Y
    Sugimachi, K
    Taguchi, T
    ANNALS OF ONCOLOGY, 1998, 9 : 164 - 164
  • [34] Extended safety and efficacy data on triple combination therapy using S-1, cisplatin, and paclitaxel in patients with advanced gastric cancer in a multicenter phase II study
    Iwase, H.
    Ina, K.
    Goto, H.
    Haruta, J.
    Kumada, T.
    Shinoda, M.
    Sugihara, M.
    Tsuzuki, T.
    Shimada, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] Phase II Study of S-1 Monotherapy as a First-line, Combination Therapy of S-1 plus Cisplatin as a Second-line, and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma Phase II Study of S-1, S-1 plus Cisplatin, and Weekly Paclitaxel in Patients with Advanced Gastric Carcinoma
    Rino, Yasushi
    Yukawa, Norio
    Wada, Nobuyuki
    Suzuki, Makoto
    Murakami, Hitoshi
    Yamada, Takanobu
    Nakayama, Hirotaka
    Yamamoto, Naoto
    Sato, Tsutomu
    Yamada, Roppei
    Ohshima, Takashi
    Masuda, Munetaka
    Imada, Toshio
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2008, 2 : 375 - 383
  • [36] A phase II study of S-1 and irinotecan combination chemotherapy in patients with advanced gastric cancer as a first-line therapy
    Ryoo, B. Y.
    Kang, H. J.
    Yang, S. H.
    Cho, S. H.
    Oh, S. J.
    Lee, M. H.
    Song, E. K.
    Chung, H. C.
    EJC SUPPLEMENTS, 2007, 5 (04): : 274 - 274
  • [37] Erratum: Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer
    W Koizumi
    K Yamaguchi
    H Hosaka
    Y Takinishi
    N Nakayama
    T Hara
    K Muro
    H Baba
    Y Sasaki
    T Nishina
    N Fuse
    T Esaki
    M Takagi
    M Gotoh
    T Sasaki
    British Journal of Cancer, 2014, 111 : 2382 - 2382
  • [38] A phase II study of combination therapy with irinotecan and S-1 (IRIS) in patients with advanced colorectal cancer
    Manabu Shiozawa
    Makoto Akaike
    Nobuhiro Sugano
    Kazuhito Tsuchida
    Naoto Yamamoto
    Soichiro Morinaga
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 987 - 992
  • [39] PHASE II STUDY OF GEMCITABINE/S-1 COMBINATION THERAPY IN PATIENTS WITH ADVANCED BILIARY TRACT CANCER
    Kanai, Masashi
    Hatano, Etsuro
    Tsumura, Takehiko
    Asada, Masanori
    Matsumoto, Shigemi
    Nishimura, Takafumi
    Hamada, Akihiko
    Inoue, Naoya
    Mori, Yukiko
    Yoshimura, Kenichi
    Tada, Shinsuke
    Yanagihara, Kazuhiro
    Yazumi, Shujiro
    Osaki, Yukio
    Chiba, Tsutomu
    ANNALS OF ONCOLOGY, 2010, 21 : 19 - 19
  • [40] A phase II study of combination therapy with irinotecan and S-1 (IRIS) in patients with advanced colorectal cancer
    Shiozawa, Manabu
    Akaike, Makoto
    Sugano, Nobuhiro
    Tsuchida, Kazuhito
    Yamamoto, Naoto
    Morinaga, Soichiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (05) : 987 - 992
12345